---
layout: archive
title: "Publications"
permalink: /publications/
author_profile: true
---

{% include base_path %}

This page features full-length papers where I am one of the authors. For conference abstracts see [Abstracts](/abstracts/)

You can also find my papers on <u><a href="{{author.googlescholar}}">my Google Scholar profile</a>.</u>

<span style="color:red">First / Joint First Author</span>; **Co-author**; \# Joint first authors; \* Corresponding author(s); <span style="color:blue">Journal or Conference</span>

# Submitted

2023
1. <ins>Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell Carcinoma</ins>, Seunghun Han, Sabrina Y. Camp, **Hoyin Chu**, Ryan Collins, Riaz Gillani, Jihye Park, Ziad Bakouny, Cora A. Ricker, Brendan Reardon, Nicholas Moore, Eric Kofman, Chris Labaki, David Braun, Toni K. Choueiri, Saud H. AlDubayan, Eliezer M. Van Allen, <span style="color:blue">medRxiv</span>, [https://doi.org/10.1101/2023.01.18.23284664](https://doi.org/10.1101/2023.01.18.23284664) (Jan 2023)

2022

1. <ins>Low-pass Whole Genome Imputation Enables the Characterization of Polygenic Breast Cancer Risk in the Indigenous Arab Population</ins>, Mohammed Al-Jumaan<sup>#</sup>, <span style="color:red">**Hoyin Chu**</span><sup>#</sup>, Abdullah Al-Sulaiman, Sabrina Y. Camp, Seunghun Han, Riaz Gillani, Yousef Al Marzooq, Fatmah Almulhim, Chitti Babu Vatte, Areej Al Nemer, Afnan Almuhanna, Eliezer M. Van Allen, Amein Al-Ali<sup>\*</sup>, Saud H. AlDubayan<sup>\*</sup>, Under Review (Submitted November 2022), <span style="color:blue">medRxiv</span>, [https://www.medrxiv.org/content/10.1101/2022.12.07.22282785v1](https://www.medrxiv.org/content/10.1101/2022.12.07.22282785v1)  (Dec 2022).

2. <ins>NIMBUS: A phase II study of nivolumab plus low dose ipilimumab in hypermutated HER2-negative metastatic breast cancer</ins>, Romualdo Barroso-Sousa, Tianyu Li, Sangeetha Reddy, Leisha A. emens, Saud H. AlDubayan, **Hoyin Chu**, Beth Overmoyer, Edward T. Richardson III, Paulina Lange, Molly K. DiLullo, Juelie Kasparian, Melissa E. Hughes, Victoria Attaya, Ameer Basta, Nancy U. Lin, Nabihah Tayob, Elizabeth A. Mittendorf, Sara M. Tolaney, Under Review (Submitted July 2022)

3. <ins>Germline loss of function variants in CHEK2 and susceptibility to Ovarian Germ Cell Tumors</ins>, Sabrina Y. Camp, Stephanie A. Cohen, Kelsey Moriarty, Seyram Doe-Tetteh, Eric R Kofman, Seunghun Han, Riaz Gillani, Brendan Reardon, Jett Crowdis, **Hoyin Chu**, Tina Alano, Darren Feldman, Anne Marie Noronha, Christopher J. Sweeney, David B. Solit, Saud H. AlDubayan, Eliezer M. Van Allen, Under Review (Submitted June 2022)

4. <ins>CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods</ins>, <em>**The Critical Assessment of Genome Interpretation Consortium**</em> <span style="color:blue">arXiv</span> [http://arxiv.org/abs/2205.05897](http://arxiv.org/abs/2205.05897)  (Submitted May 2022).


<br/>

# Peer-Reviewed

2023

1. <ins>Profiling of pharmacogenomic variants in CYP2D6 and DPYD in indigenous Arab breast cancer patients</ins> <em>Abdullah Al-Sulaiman<sup>#</sup>, <span style="color:red">**Hoyin Chu**</span><sup>#</sup>, Mohammed Al-Jumaan, Mohammed Alyahya, Yousef Al Marzooq, Fatmah Almulhim, Chitti Babu Vatte, Areej Alnimer, Afnan Almuhanna, Amein Al-Ali<sup>\*</sup>, Saud H AlDubayan<sup>\*</sup></em>, [Pharmacogenomics 24 (7): 411–23.](https://pubmed.ncbi.nlm.nih.gov/37222147/) (Published May 2023)

2. <ins>Using Association Rules to Understand the Risk of Adverse Pregnancy Outcomes in a Diverse Population</ins>,  <em><span style="color:red">**Hoyin Chu**</span>, Rashika Ramola, Shantanu Jain, David M. Haas, Sriraam Natarajan, Predrag Radivojac<sup>\*</sup></em>, accepted for publication and **oral presentation**, <span style="color:blue">Pacific Symposium on Biocomputing</span>, [PubMed Central ID: PMC9782715](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782715/), (Published Jan 2023)

2022

1. <ins>[The influence of genetic predisposition and physical activity on risk of Gestational Diabetes Mellitus in the nuMoM2b cohort](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2795756)</ins>, <em>Kymberleigh A. Pagel<sup>#</sup>, <span style="color:red">**Hoyin Chu**</span><sup>#</sup>, Rashika Ramola<sup>#</sup>,  Rafael F. Guerrero, Judith H. Chung, Samuel Parry, Uma M. Reddy, Robert M. Silver, Jonathan G. Steller, Lynn M. Yee, Ronald J. Wapner, Matthew W. Hahn, Sriraam Natarajan, David M. Haas<sup>\*</sup>, Predrag Radivojac<sup>\*</sup></em> <span style="color:blue">JAMA Network Open</span>, doi:10.1001/jamanetworkopen.2022.29158 (Published July 2022)

2. <ins>[Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes](https://doi.org/10.1016/j.ajhg.2022.04.007)</ins>, <em>Riaz Gillani, Sabrina Y. Camp, Seunghun Han, Jill K. Jones, **Hoyin Chu**, Schuyler O’Brien, Erin L. Young, Lucy Hayes, Gareth Mitchell, Trent Fowler, Alexander Gusev, Junne Kamihara, Katherine A. Janeway, Joshua D. Schiffman, Brian D. Crompton<sup>\*</sup>, Saud H. AlDubayan<sup>\*</sup>, Eliezer M. Van Allen<sup>\*</sup></em>, <span style="color:blue">The American Journal of Human Genetics</span>, [https://doi.org/10.1016/j.ajhg.2022.04.007](https://doi.org/10.1016/j.ajhg.2022.04.007) (Published May 2022)

<br/>

---
<a href="#top">Back to top</a>
<br/>
Last update: 2023-08-22

<!-- {% if author.googlescholar %}
  You can also find my articles on <u><a href="{{author.googlescholar}}">my Google Scholar profile</a>.</u>
{% endif %} -->
<!-- 
{% include base_path %}

{% for post in site.publications reversed %}
  {% include archive-single.html %}
{% endfor %} -->
